These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 27334577)

  • 1. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z; Xu M; Hu Z; Shrestha UK
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and associated metabolic factors of fatty liver disease in the elderly.
    Wang Z; Xu M; Peng J; Jiang L; Hu Z; Wang H; Zhou S; Zhou R; Hultström M; Lai EY
    Exp Gerontol; 2013 Aug; 48(8):705-9. PubMed ID: 23721951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of Clinical Profile of Patients of Non Alcoholic Fatty Liver Disease and its Association with Metabolic Syndrome.
    Gaharwar R; Trikha S; Margekar SL; Jatav OP; Ganga PD
    J Assoc Physicians India; 2015 Jan; 63(1):12-6. PubMed ID: 26591121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].
    Guijarro de Armas MG; Monereo Megías S; Navea Aguilera C; Merino Viveros M; Vega Piñero MB
    Med Clin (Barc); 2015 Jan; 144(2):55-8. PubMed ID: 24768200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
    Du T; Yu X; Yuan G; Zhang J; Sun X
    Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
    [TBL] [Abstract][Full Text] [Related]  

  • 11.  Most overweight and obese Indian children have nonalcoholic fatty liver disease.
    Pawar SV; Zanwar VG; Choksey AS; Mohite AR; Jain SS; Surude RG; Contractor QQ; Rathi PM; Verma RU; Varthakavi PK
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):853-861. PubMed ID: 27740518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
    Chakrabarty M; Jha AN; Sharma DJ
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.
    Olusanya TO; Lesi OA; Adeyomoye AA; Fasanmade OA
    Pan Afr Med J; 2016; 24():20. PubMed ID: 27583084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: A large Dutch population cohort.
    van den Berg EH; Amini M; Schreuder TC; Dullaart RP; Faber KN; Alizadeh BZ; Blokzijl H
    PLoS One; 2017; 12(2):e0171502. PubMed ID: 28152105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between elevated serum alanine aminotransferase and cardiometabolic risk factors in rural Chinese population: a cross-sectional study.
    Chen S; Guo X; Zhang X; Yu S; Yang H; Jiang M; Sun G; Sun Y
    BMC Cardiovasc Disord; 2015 Jul; 15():65. PubMed ID: 26160405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.
    Abeysekera KWM; Fernandes GS; Hammerton G; Portal AJ; Gordon FH; Heron J; Hickman M
    Lancet Gastroenterol Hepatol; 2020 Mar; 5(3):295-305. PubMed ID: 31954687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease (NAFLD) and significant hepatic fibrosis defined by non-invasive assessment in patients with type 2 diabetes.
    Sobhonslidsuk A; Pulsombat A; Kaewdoung P; Petraksa S
    Asian Pac J Cancer Prev; 2015; 16(5):1789-94. PubMed ID: 25773826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
    Prasetya IB; Hasan I; Wisnu W; Rumende CM
    Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of noninvasive methods for the characterization of nonalcoholic liver steatosis in the family practice. The "VARES" Italian multicenter study.
    Grattagliano I; Ubaldi E; Napoli L; Marulli CF; Nebiacolombo C; Cottone C; Portincasa P
    Ann Hepatol; 2013; 12(1):70-7. PubMed ID: 23293196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.